Top

Current Diabetes Reports

Published in:

01-11-2018 | Psychosocial Aspects (SS Jaser, Section Editor)

Diabetes, Depression, and Cognition: a Recursive Cycle of Cognitive Dysfunction and Glycemic Dysregulation

Authors: Sheila Black, Kyle Kraemer, Avani Shah, Gaynell Simpson, Forrest Scogin, Annie Smith

Published in: Current Diabetes Reports | Issue 11/2018

Abstract

Purpose of Review

The study aims to examine the effects of diabetes and depression on executive functioning (EF) and to review the effects of EF deficits on diabetes management.

Recent Findings

Both type 2 diabetes and depression influence EF, and in turn, EF has an impact on diabetes management.

Summary

Individuals with both comorbidities (i.e., diabetes and depression) experience greater deficits in EF than individuals with just one of the morbidities (i.e., depression or diabetes). The disruption in EF results in poor diabetes management and poor emotion regulation which ultimately increases the probability of a recursive cycle of depression and hyperglycemia. This recursive cycle can ultimately lead to diabetes-related complications.

Gupta D, Radhakrishnan M, Kurhe Y. Insulin reverses anxiety-like behavior evoked by streptozotocin-induced diabetes in mice. Metab Brain Dis 2014 04/25.

Tunceli K, Bradley CJ, Nerenz D, Williams LK, Pladevall M, Elston LJ. The impact of diabetes on employment and work productivity. Diabetes Care. 2005;28(11):2662–7.CrossRef

Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–21.CrossRef

Ho N, Sommers MS, Lucki I. Effects of diabetes on hippocampal neurogenesis: Links to cognition and depression. Neurosci Biobehav Rev. 2013;37(8):1346–62.CrossRef

Gregg EW, Brown A. Cognitive and physical disabilities and aging-related complications of diabetes. Clinical Diabetes. 2003.

Rubin RR, Wadden TA, Bahnson JL, Blackburn GL, Brancati FL, Bray GA, et al. Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial. Diabetes Care. 2014; https://doi.org/10.2337/dc13-1928. [6]

Gregg EW, Beckles GL, Williamson DF, Leveille SG. Langlois JA. Narayan KM. Diabetes and physical disability among older U.S. adults. Diabetes Care: Engelgau MM; 2000. [7]

• Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord, 2012, s8-s21. This article reviews the epidemiology of co-morbid depression and concludes that depression is quite prevalent among individuals with Type 2 diabetes but that more longitudinal studies are needed to determine the nature of the relationship and before any conclusions about causality can be made.

Atlantis E. Excess burden of type 1 and type 2 diabetes due to psychopathology. J Affect Disord. 2012;142:S36–41.CrossRef

10.

• Lloyd CE, Roy T, Nouwen A, Chauhan AM. Epidemiology of depression in diabetes: international and cross-cultural issues. J Affect Disord. 2012;142:S22–9. This paper considers the risk factors for individuals with diabetes developing depression, from a cross-cultural perspective. There is also a discussion about the consequences of depression for individuals with diabetes. CrossRef

11.

Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the world health surveys. Lancet. 2007;370(9590):851–8.CrossRef

12.

Silva N, Atlantis E, Ismail K. A review of the association between depression and insulin resistance: pitfalls of secondary analyses or a promising new approach to prevention of type 2 diabetes? Curr Psychiatry Rep. 2012;14:8–14.CrossRef

13.

Watari K, Elderkin-Thompson V, Ajilore O, Haroon E, Darwin C, Pham D, et al. Neuroanatomical correlates of executive functioning in depressed adults with type 2 diabetes. J Clin Exp Neuropsychol 2008;30(4):389–397.CrossRef

14.

Ryan CM, van Duinkerken E, Rosano C. Neurocognitive consequences of diabetes. Am Psychol. 2016;71(7):563.CrossRef

15.

Houben K, Dassen FC, Jansen A. Taking control: working memory training in overweight individuals increases self-regulation of food intake. Appetite. 2016;105:567–74.CrossRef

16.

Tabák AG, Akbaraly TN, Batty GD, Kivimäki M. Depression and type 2 diabetes: a causal association? Lancet Diabetes Endocrinol. 2014;2(3):236–45.CrossRef

17.

Ruis C, Donk M, Biessels GJ, Kapplle LJ, Gortter KJ, Rutten G. Cognition in the early stage of type 2 diabetes. Diabetes Care. 2009;32:1261–5.CrossRef

18.

Becker S, Wojtowicz JM. A model of hippocampal neurogenesis in memory and mood disorders. Trends Cogn Sci (Regul Ed ). 2007;11(2):70–6.CrossRef

19.

Cukierman-Yaffe T. Diabetes, dysglycemia and cognitive dysfunction. Diabetes Metab Res Rev. 2014;30(5):341–5.CrossRef

20.

•• Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, Miller ME, et al. Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial. Diabetes Care. 2009;32(2):221–6. Interesting article about the relation between glycemic control and cognition. CrossRef

21.

Munshi MN, Hayes M, Iwata I, Lee Y, Weinger K. Which aspects of executive dysfunction influence ability to manage diabetes in older adults? Diabet Med. 2012;29(9):1171–7.CrossRef

22.

• Hofmann W, Schmeichel BJ, Baddeley AD. Executive functions and self-regulation. Trends Cogn Sci. 2012;16(3):174–80. This paper describes the way in which executive function is extremely important for self-regulation CrossRef

23.

• Feil D, Zhu C, Sultzer D. The relationship between cognitive impairment and diabetes self-management in a population-based community sample of older adults with Type 2 diabetes. J Behav Med. 2012;35(2):190–9. Describes the effects of cognitive impairment on diabetes self-care.CrossRef

24.

• Miyake A, Friedman NP. The unity and diversity of executive functions and their contributions to complex ‘frontal lobe’ tasks: a latent variable analysis. Cognit Psychol. 2000;41(1):49. This is a classic paper describing a very important mode of Executive Function. CrossRef

25.

Dixon ML, Thiruchselvam R, Todd R, Christoff K. Emotion and the prefrontal cortex: an integrative review. Psychol Bull. 2017;143(10):1033–81.CrossRef

26.

Lee JH, Choi Y, Jun C, Hong YS, Cho HB, Kim JE, et al. Neurocognitive changes and their neural correlates in patients with type 2 diabetes mellitus. Endocrinol Metab. 2014;29(2):112–21.CrossRef

27.

Lyoo I, Yoon S, Jacobson AM, et al. Prefrontal cortical deficits in type 1 diabetes mellitus: brain correlates of comorbid depression. Arch Gen Psychiatry. 2012;69(12):1267–76.CrossRef

28.

Baker LD, Cross DJ, Minoshima S, Belongia D, Watson G, Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol. 2011;68(1):51–7.CrossRef

29.

Cohen N, Henik A, Moyal N. Executive control attenuates emotional effects—For high reappraisers only? Emotion 2012 10;12(5):970–979.CrossRef

30.

Roriz-Filho S,J, Sá-Roriz TM, Rosset I, Camozzato AL, Santos AC, Chaves MLF, et al. (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta. 2009;1792(5):432–43.CrossRef

31.

Huang R, Jia B, Xie L, Ma S, Yin J, Sun Z, et al. Spatial working memory impairment in primary onset middle-age type 2 diabetes mellitus: an ethology and BOLD-fMRI study. J Magn Reson Imaging. 2016;43(1):75–87.CrossRef

32.

He X, Wang Z, Zhu Y, Wang N, Hu X, Zhang D, et al. Hyperactivation of working memory-related brain circuits in newly diagnosed middle-aged type 2 diabetics. Acta Diabetol. 2014;01(01):1–10.

33.

Munshi M, Capelson R, Grande L, Lin S, Hayes M, Milberg W, et al. Cognitive Dysfunction Is Associated With Poor Diabetes Control in Older Adults. Diabetes Care. 2006;29(8):1794–9.CrossRef

34.

Grande LJ, Rudolph JL, Milberg WP, Barber CE, McGlinchey RE. Detecting cognitive impairment in individuals at risk for cardiovascular disease: the “clock-in-the-box” screening test. Int J Geriatr Psychiatry. 2011;26(9):969–75.CrossRef

35.

Royall DR, Cordes JA, Polk M. CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry. 1998 May;64(5):588–94.CrossRef

36.

Nazaribadie M, Amini M, Ahmadpanah M, Asgari K, Jamlipaghale S, Nazaribadie S. Executive functions and information processing in patients with type 2 diabetes in comparison to pre-diabetic patients. J Diabetes Metab Disord. 2014;13(1):27–33.CrossRef

37.

Dohle S, Diel K, Hofmann W. Executive functions and the self-regulation of eating behavior: a review. Appetite. 2017;

38.

Allom V, Mullan B. Individual differences in executive function predict distinct eating behaviours. Appetite. 2014;80:123–30.CrossRef

39.

Whitelock V, Nouwen A, Houben K, van den Akker O, Rosenthal M, Higgs S. Does working memory training improve dietary self-care in type 2 diabetes mellitus? Diabetes Res Clin Pract: Results of a double blind randomised controlled trial; 2018.

40.

• Spitznagel MB, Garcia S, Miller LA, Strain G, Devlin M, Wing R, et al. Cognitive function predictsweight loss after bariatric surgery. Surg Obes Relat Dis. 2013;9(3):453–9. Interesting study about the relation between executive function and dietary behavior. CrossRef

41.

Shimamura AP. Toward a cognitive neuroscience of metacognition. Conscious Cogn. 2000;9:313–23.CrossRef

42.

Kelly A, Calamia M, Koval A, Terrera GM, Piccinin AM, Clouston S, et al. Independent and interactive impacts of hypertension and diabetes mellitus on verbal memory: A coordinated analysis of longitudinal data from England, Sweden, and the United States. Psychol Aging. 2016;31(3):262–73.CrossRef

43.

van Bussel FC, Backes WH, Hofman PA, van Boxtel MP, Schram MT, Stehouwer CD, et al. Altered hippocampal white matter connectivity in type 2 diabetes mellitus and memory decrements. J Neuroendocrinol. 2016;

44.

Ajilore O, Lamar M, Medina J, Watari K, Elderkin-Thompson V, Kumar A. Disassociation of verbal learning and hippocampal volume in type 2 diabetes and major depression. Int J Geriatr Psychiatry. 2015;30(4):393–9.CrossRef

45.

De Felice FG, Benedict C. A key role of insulin receptors in memory. Diabetes. 2015;64(11):3653–5.CrossRef

46.

Pandey SP, Singh HK, Prasad S. Alterations in hippocampal oxidative stress, expression of AMPA receptor GluR2 subunit and associated spatial memory loss by Bacopa monnieri extract (CDRI-08) in Streptozotocin-induced diabetes mellitus type 2 mice. PLoS One. 2015;7

47.

Vieira ER, Mendy A, Prado CM, Gasana J, Albatineh AN. Falls, physical limitations, confusion and memory problems in people with type II diabetes, undiagnosed diabetes and prediabetes, and the influence of vitamins a, D and E. J Diabetes Complicat. 2015;29:1159–64.CrossRef

48.

Lamport DJ, Lawton CL, Mansfield MW, Moulin CAJ, Dye L. Type 2 diabetes and impaired glucose tolerance are associated with word memory source monitoring recollection deficits but not simple recognition familiarity deficits following water, low glycaemic load, and high glycaemic load breakfasts. Physiol Behav. 2014;124:54–60.CrossRef

49.

Kitamura T, Inokuchi K. Role of adult neurogenesis in hippocampal-cortical memory consolidation. Molecular Brain. 2014;7:1–8.CrossRef

50.

McCabe DP, Roediger HLI II, McDaniel MA, Balota DA, Hambrick DZ. The relationship between working memory capacity and executive functioning: Evidence for a common executive attention construct. Neuropsychology. 2010;24(2):222–43.CrossRef

51.

Kaschel R, Kazén M, Kuhl J. State orientation and memory load impair prospective memory performance in older compared to younger persons. Aging Neuropsychol Cognit. 2017;24(4):453–69.CrossRef

52.

Woods SP, Dawson MS, Weber E, Gibson S, Grant I, Atkinson JH, et al. Timing is everything: antiretroviral nonadherence is associated with impairment in time-based prospective memory. J Int Neuropsychol Soc. 2009;15(1):42–52.CrossRef

53.

• Vedhara K, Wadsworth E, Norman P, Searle A, Mitchell J, Macrae N, et al. Habitual prospective memory in elderly patients with Type 2 diabetes: implications for medication adherence. Psychol Health Med. 2004;9(1):17–27. Very interesting study focusing on the effects of diabetes on prospective memory. CrossRef

54.

Bottiroli S, Vecchi T, Campanella F, Varetta A, Gallotti MC, Perego E, et al. Executive functioning in older adult outpatients with type 2 diabetes mellitus: a preliminary study. Clin Gerontol. 2014;37(2):91–107.CrossRef

55.

Smith MA, Else JE, Wesnes KA, Riby LM, Paul L, Foster JK, et al. Functional living in older adults with type 2 diabetes: Executive functioning, dual task performance, and the impact on postural stability and motor control. J Aging Health. 2014;26(5):841–59.CrossRef

56.

Lavigne JE, Phelps CE, Mushlin A, Lednar WM. Reductions in individual work productivity associated with type 2 diabetes mellitus. Pharmacoeconomics. 2003;21(15):1123–34.CrossRef

57.

Salehinejad MA, Ghanavai E, Rostami R, Nejati V. Cognitive control dysfunction in emotion dysregulation and psychopathology of major depression (MD): evidence from transcranial brain stimulation of the dorsolateral prefrontal cortex (DLPFC). J Affect Disord. 2017;210:241–8.CrossRef

58.

Joormann J, Tanovic E. Cognitive vulnerability to depression: examining cognitive control and emotion regulation. Curr Opin Psychol. 2015;4:86–92.CrossRef

59.

• Snyder HR. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol Bull. 2013;139(1):81. Provides an important review of the neuropsychological effects of depression. CrossRef

60.

De Lissnyder E, Koster EH, Everaert J, Schacht R, Van den Abeele D, De Raedt R. Internal cognitive control in clinical depression: general but no emotion-specific impairments. Psychiatry Res. 2012;199(2):124–30.CrossRef

61.

Dalby RB, Frandsen J, Chakravarty MM, Ahdidan J, Sørensen L, Rosenberg R, et al. Correlations between Stroop task performance and white matter lesion measures in late-onset major depression. Psychiatry Res Neuroimaging. 2012;202(2):142–9.CrossRef

62.

Epp AM, Dobson KS, Dozois DJA, Frewen PA. A systematic meta-analysis of the Stroop task in depression. Clin Psychol Rev. 2012;32(4):316–28.CrossRef

63.

• Koster EH, De Lissnyder E, Derakshan N, De Raedt R. Understanding depressive rumination from a cognitive science perspective: the impaired disengagement hypothesis. Clin Psychol Rev. 2011;31(1):138–45. Provides a model of rumination from a cognitive perspective. CrossRef

64.

Grahek I, Everaert J, Krebs R, Koster EHW. Preprint: Cognitive Control in Depression: Toward Clinical Models Informed by Cognitive Neuroscience 2018. doi:https://doi.org/10.31219/osf.io/qt72z.

65.

Genet JJ, Malooly AM, Siemer M. Flexibility is not always adaptive: affective flexibility and inflexibility predict rumination use in everyday life. Cognit Emot. 2013;27(4):685–69571.CrossRef

66.

Joormann J, Gotlib IH. Updating the contents of working memory in depression: interference from irrelevant negative material. J Abnorm Psychol. 2008;117(1):182–92.CrossRef

67.

Paxton JL, Barch DM, Racine CA, Braver TS. Cognitive control, goal maintenance, and prefrontal function in healthy aging. Cereb Cortex. 2007;18(5):1010–28.CrossRef

68.

• Belleau E, Taubitz LE, Larson CL. Imbalance of default mode and regulatory networks during externally focused processing in depression. Soc Cogn Affect Neurosci. 2015;10(5):744–51. Describes the physiological basis for rumination among individuals with depression. CrossRef

69.

Lee JH, Choi Y, Jun C, Hong YS, Cho HB, Kim JE, et al. Neurocognitive changes and their neural correlates in patients with type 2 diabetes mellitus. Endocrinol Metab. 2014;29(2):112–21.CrossRef

70.

Le DS, Pannacciulli N, Chen K, Salbe AD, Hill JO, Wing RR, et al. Less activation in the left dorsolateral prefrontal cortex in the reanalysis of the response to a meal in obese than in lean women and its association with successful weight loss. Am J Clin Nutr. 2007;86(3):573–9.CrossRef

71.

Gyurak A, Goodkind MS, Kramer JH, Miller BL, Levenson RW. Executive functions and the down-regulation and up-regulation of emotion. Cognit Emot. 2012;26(1):103–18.CrossRef

72.

Joormann J, Tanovic E. Cognitive vulnerability to depression: examining cognitive control and emotion regulation. Curr Opin Psychol 2015;4:86–92. 2016;190:744–753.CrossRef

73.

Hubbard NA, Hutchison JL, Turner M, Montroy J, Bowles RP, Rypma B. Depressive thoughts limit working memory capacity in dysphoria. Cognit Emot. 2016;30(2):193–209.CrossRef

74.

Friedman NP, Miyake A. Unity and diversity of executive functions: Individual differences as a window on cognitive structure. Cortex 2017 January 2017;86:186–204.CrossRef

75.

Mansur RB, Brietzke E, McIntyre RS. Review: is there a “metabolic-mood syndrome”? A review of the relationship between obesity and mood disorders. Neurosci Biobehav Rev. 2015;52:89–104.CrossRef

76.

van Duinkerken E, Snoek FJ. Interaction between Diabetes and Depression: Consequences for Cognition and the Brain. Curr Med Lit: Psychiatry. 2012;23(3):69–78.

77.

Park M, Katon WJ, Wolf FM. Depression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review. Gen Hosp Psychiatry. 2013;35(3):217–25.CrossRef

78.

Deschênes SS, Burns RJ, Schmitz N. Associations between diabetes, major depressive disorder and generalized anxiety disorder comorbidity, and disability: findings from the 2012 Canadian community health survey—mental health (CCHS-MH). J Psychosom Res. 2015;78(2):137–42.CrossRef

79.

• Sullivan MD, Katon WJ, Lovato LC, et al. Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the accord-mind trial. JAMA Psychiatry. 2013;1:70. Study describes the effects of co-morbid depression and diabetes on cognition.

80.

Lustman PJ, Clouse RE. Depression in diabetic patients: The relationship between mood and glycemic control. J Diabetes Complicat. 2005;19(2):113–22. (10):1041–1047PubMed

81.

Janocha A, Bolanowski M, Pilecki W, Małyszczak K, Salomon E, Woźniak W, et al. Cognitive disorders in type 2 diabetic patients with recognized depression. Neuro Endocrinol Lett. 2010;31(3):399–405.PubMed

82.

Pompili M, Lester D, Innamorati M, De Pisa E, Amore M, Ferrara C, et al. Quality of life and suicide risk in patients with diabetes mellitus. Psychosomatics. 2009;50(1):16–23.98.CrossRef

83.

Russo J, Katon W, Lin E, Von Korff M, Bush T, Simon G, et al. Neuroticism and extraversion as predictors of health outcomes in depressed primary care patients. Psychosomatics. 1997;38(4):339–48.CrossRef

84.

Lahey BB. Public health significance of neuroticism. Am Psychol. 2009;64(4):241–56.CrossRef

85.

Cohen N, Mor N, Henik A. Linking executive control and emotional response: a training procedure to reduce rumination. Clin Psychol Sci. 2015;3(1):15–25.CrossRef

86.

Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology. 1999;53(9):1937–42.CrossRef

Title: Diabetes, Depression, and Cognition: a Recursive Cycle of Cognitive Dysfunction and Glycemic Dysregulation
Authors: Sheila Black
Kyle Kraemer
Avani Shah
Gaynell Simpson
Forrest Scogin
Annie Smith
Publication date: 01-11-2018
Publisher: Springer US
Published in: Current Diabetes Reports / Issue 11/2018
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-018-1079-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 11/2018

Glycemic Outcomes of Islet Autotransplantation

Advancing Measurement of Diabetes at the Population Level

Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field

Lifestyle Factors Affecting the Gut Microbiota’s Relationship with Type 1 Diabetes

Autonomic Regulation of Glucose Homeostasis: a Specific Role for Sympathetic Nervous System Activation

Building Toward a Population-Based Approach to Diabetes Screening and Prevention for US Adults

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials